Newsroom
Posted on September 12, 2017

Michelin North America Obtains Settlement In Lawsuit Against Tire Recappers of Nashville

Michelin’s claim centered on its patented tread designs

for BFGoodrich Mud-Terrain T/A KM2 and Michelin LTX M/S2 tires

GREENVILLE, S.C., Sept. 12, 2017 Michelin North America, Inc., has settled its lawsuit against Tire Recappers of Nashville, which focused on design patent infringements for the popular BFGoodrich Mud-Terrain T/A® KM2 and Michelin® LTX® M/S2 tires produced by Michelin in the United States. The companies have agreed not to disclose terms of the settlement.

“Michelin monitors the marketplace for infringements of our intellectual property at every performance level and price point,” said Scott Clark, chief operating officer for Michelin North America, and head of the Company’s passenger tire unit. “Michelin will continue to pursue aggressive legal action to protect our products that are covered by our intellectual property.”

Michelin filed its lawsuit in U.S. District Court for the Middle District of Tennessee in Nashville (Michelin North America, Inc. v. Tire Recappers of Nashville, Inc.; case no. 3:17-cv-01015). The suit claimed that two tire models by Tire Recappers of Nashville — the Cross Grip M/T and the All Position Highway 2 — infringe Michelin’s U.S. Patent Nos. D530,266 and D639,235.

About Michelin North America

Dedicated to the improvement of sustainable mobility, Michelin designs, manufactures and sells tires for every type of vehicle, including airplanes, automobiles, bicycles, earthmovers, farm equipment, heavy-duty trucks and motorcycles. The company has earned a long-standing reputation for building innovative premium tires.  In addition to tires, the company also publishes travel guides, hotel and restaurant guides, maps and road atlases. Headquartered in Greenville, S.C., Michelin North America (www.michelinman.com) employs about 22,700 and operates 19 major manufacturing plants.




 

FILED UNDER:
Category: Corporate
0 Comments
Be the first to comment.
Leave a Comment